This course was presented in person at World Sleep 2025 in Singapore.

To access the session recording, navigate to the content tab and click the view video button. 

Session Schedule

Find a specific presentation in the course by navigating to the timestamp indicated below.

0:00:00
Introduction

0:02:10
Insomnia pharmacotherapy in adults
David Neubauer (United States)

1:00:05
Insomnia pharmacotherapy in children and adolescents
Judith Owens (United States)

1:44:00
Question and answer

2:01:50
Hypnotics polypharmacy: Its risk factor and management
Yuichi Inoue (Japan)

2:34:15
Advantages and disadvantages of combining CBT-I with sleep-promoting medications
Yun Kwok Wing (Hong Kong)

3:17:00
Question and answer

Course Summary:

The use of medications in the treatment of insomnia remains an important therapeutic option. As more compounds and formulations have become available there now are greater opportunities for personalizing care for patients based on their symptoms and circumstances, as well as medication pharmacologic properties. This course will review the key features of approved insomnia disorder medications as well as commonly prescribed “off-label” medications, over-the-counter sleep aid products, and dietary supplements, such as melatonin. Separate lectures will focus on pharmacologic approaches in adults (Dr. Neubauer) and in children and adolescents (Dr. Owens). The development and clinical significance of hypnotic medication polypharmacy will be discussed by Dr. Inoue. Finally, Dr. Wing will provide an up-to-date review of combining insomnia pharmacotherapy with CBT-I.

Learning Objectives:

Upon completion of this CME activity, participants will be able to:
• Compare and contrast medications indicated for the treatment of insomnia disorder in children, adolescents, and adults
• Review the use of off-label medications, over-the-counter sleep aids, and dietary supplements for treating insomnia in children, adolescents, and adults
• Discuss key factors that contribute to personalized care in the pharmacologic management of insomnia
• Review the development, clinical significance, and resolution of hypnotic polypharmacy